Last edition
News about "Syngene"
Biocon Posts Robust Q2FY26 Results as Biosimilars and Generics Drive Double-Digit Growth
Biocon reported a robust financial performance for the second quarter of FY26, with total revenue rising 21 percent year-on-year (YoY) to INR 4,389 crore, compared to INR 3,623 crore in Q2 FY25.
Syngene | 12/11/2025 | By Dineshwori | 382
Syngene Acquires its First Manufacturing Facility in US
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L for large molecule discovery, development, and manufacturing services.
Syngene | 11/03/2025 | By Aishwarya | 514
Syngene to acquire multi-modal facility from Stelis Biopharma Ltd
Syngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,000 liters of installed biologics drug substance manufacturing capacity, with scope for further expansion, and a high speed, commercial scale, fill-finish unit
Syngene | 06/07/2023 | By Sudeep Soparkar | 645
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy